Cevad Şekuri

İlgilendiği Konular

Sunulan Hizmetler

Görev Yaptığı Kurumlar

Deneyim

• Prof.Dr. Cevad Şekuri Muayenehanesi

  2023 - Günümüz

• Medicana Hastanesi

  2020 - 2023

• Kent Hastanesi Doç. Dr.

  2004 - 2020

• Celal Bayar Üniversitesi Yard. Doç. Dr.

  1999 - 2004

• Ege Üniversitesi Kardiyoloji

  1994 - 1998

Eğitim

• EGE ÜNİVERSİTESİ

  Yüksek Lisans / Uzmanlık

• EGE ÜNIVERSITESI

  Yüksek Lisans / Uzmanlık

Yayın & Araştırma

• 6.1 Uluslararası SCI-SCIE-AHSI kapsamındaki hakemli dergilerde yayınlanan makaleler

• A1. Gök G, Zoghi M, Sinan ÜY, Kılıç S, Tokgözoğlu L; On behalf of Elder-Turk study investigators. Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey. Anatol J Cardiol. Mar;21

• A2. Gök G, Sinan ÜY, Özyüncü N, Zoghi M; ELDER-TÜRK Investigators. The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the EL

• A3. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet

• A4. Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. The global cardiovascular risk transition: associatio

• A5. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucos

• A6. Yılmaz, E., Eser, E., Sekuri, C., Kültürsay, H., ‘‘ Miyokard Enfarktüsü Boyutsal Değerlendirme Ölçeği (MIDAS) Türkçe Sürümünün pskometrik Özellikleri’’, The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Ass

• A7. Taşkıran P, Cam SF, Sekuri, C., Tüzün N., Alioğlu E, Altıntaş N ve A., Berdeli A. ‘‘ Paraoksonaz Geninde Leu-Met (55) ve Gin-Arg (192) Polimorfizmi ile Koroner Arter Hastalığı Arasındaki İlişki’’, ’The relationship between paraoxanase gene Leu-Me

• A8. Cam, S., Sekuri, C., Sagcan, A., Ercan E., Tengiz I., Alioglu E., A., Berdeli, ‘‘ Effect of monocyte chemoattractant protein-1(MCP-1)d gene polymorphism in Turkish patients with premature coronary artery disease’’. Scand J Clin Lab Invest, 68(8):

• A9. Sekuri, C., Utuk, O., Bayturan, O., Kurhan, Z., Bilge, A.R. ve T., Tavli, ‘‘Effect of Losartan on Exercise Tolerance and Echocardiographic Parameters in Patients with Moderate Mitral Regurgitation,’’ J. Renin. Angiotensin. Aldosterone. syst, Jun;

• A10. İyem, H., Sekuri, C., Tavli, M. ve S., Buket, ‘‘Left ventricular hypertrophy and remodeling after aortic valve replacement,’’ Asian Cardiovasc Thorac Ann. Dec;15(6):459-62 (2007).

• A11. Bayrak, P., Kirmaz, C., Sekuri, C. ve H., Yüksel, ‘‘Is pulmonary arterial pressure affected by allergic rhinitis with nasal obstruction?,’’ Asian Pac J Allergy Immunol. Jun-Sep;25(2-3):121-6 (2007).

• A12. Sekuri, C., Cam, F.S., Sagcan, A., Ercan, E., Tengiz, I., Alioglu, E ve A., Berdeli, ‘‘No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort,’’ Coron Artery Dis. Aug;18(5):333-7 (

• A13. Cam, S., Colakoglu, M., Colakoglu, S., Sekuri, C. ve A. Berdeli, ‘‘ACE I/D Gene Polymorphism and Aerobic Endurance Development in Response to Training in a Non-elit Female Cohort,’’ J Sports Med Phys Fitness.,47(2):234-238 (2007).

• A14. Ozturkcan, S., Turel, A., Sekuri, C. ve B. Kılıççıoğlu, ‘‘Cardiovascular Finding and psoriasis,’’ Ann Saudi med., 26, 159-161 (2006).

• A15. Gok S, Vatansever S, Vural K, Sekuri C, Izanli A, Tezcan A ve S., Cilaker, ‘‘The role of ATP sensitive K(+) channels and of nitric oxide synthase on myocardial ischemia/reperfusion-induced apoptosis,’’ Acta Histochem. 108, 95-104 (2006).

• A16. Gok, Ş., Vural, K. ve C. Sekuri, ‘‘Effect of the cardioselective KATP channel blocker HMR 1098 on ischemia-reperfusion arrhythmias in isolated perfused rat heart,’’. Vascular Pharmacol., 44, 197-205 (2006).

• A17. Cam, Sirri F., Sekuri, C., Tengiz, I., Ercan, E., Sagcan, A., Akin, M. ve A. Berdeli, ‘‘The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population,’’ Thromb. Res.

• A18. Sekuri, C., Sirri Cam, F., Ercan, E., Tengiz E., Sagcan, A., Eser, E., Berdeli, A. ve M. Akin, ‘‘Renin-angiotensin system gene polymorphisims and premature coronary artery disease,’’ J. Renin. Angiotensin. Aldosterone. syst, Mar;6(1):38-42 (200

• A19. Cam, FS., Colakoglu, M., Sekuri, C., Colakoglu, S., Sahan, C. ve A. Berdeli, ‘‘Association Between the ACE I/D Gene Polymorphism and Physical Performance in a Homogeneous Non-elıte Cohort,’’ Can. J. Appl. Physiol, 30, 74-86 (2005).

• A20. Hasdemir, C., Sagcan, A., Sekuri, C., Ildizli, M., Ulucan, C. ve C. Ceylan, ‘‘ Isotretinoin (13-cis-retinoic acid) associated atrial tachicardia,’’ Pacing Clin Electrophysiol, 28, 348-349 (2005).

• A21. Berdeli, A., Sekuri, C., Cam, FS., Ercan, E., Sagcan, A., Tengiz, İ., Eser, E. ve M. Akın, ‘‘ Association between the eNOS (Glu298Asp) and the RAS Genes Polymorphisms and Premature Coronary Artery Disease in a Turkish Population,’’ Clin. Chimic

• A22. Bayturan, O., Tezcan, UK., Sekuri, C., Bilge, AR., Utuk, O. ve E. Eser, ‘‘The Effect Of Tirofiban Treatment On ST Segment Resolution In Patients Wıth Non-ST Elevated Myocardial Infarction,’’ Jpn. Heart. J, 45, 913-920, (2004).

• A23. Gündüz, Mİ., Gümüş, BH. ve C. Şekuri, ‘‘Relationship between metabolic syndrome and erectile dysfunction,’’ Asian. J. andro, 6, 355-358, (2004).

• A24. Ercan, E., Tengiz, I., Duman, C., Sekuri, C., Aliyev, E., Mutlu, B., Ercan, HE. ve M. Akin, ‘‘Decreased plasminogen activator inhibitor-1 levels in coronary artery aneurysmatic patients,’’ J Thromb Thrombolysis., 17, 207-11 (2004).

• A25. Tengiz, I., Ercan, E., Aliyev, E., Sekuri, C., Duman, C., Akin, M. ve İ. Nalbantgil, ‘‘Elevated Levels of Matrix Metalloproteinase-3 in Coronary Aneurysmatic Patients: a case control study,’’ Curr. Control. Trials Cardiovasc. Med. 5, 10 (2004).

• A26. Ercan, E., Tengiz, I., Altuglu, I., Sekuri, C., Aliyev, E., Ercan, H. E. ve M. Akin, ‘‘Atorvastatın Treatment Decrease Inflammatory And Proleolytic Activity İn Patients With Hypercholesterolemia’’ Kardiol. Pol., 60, 454-457 (2004).

• A27. Ercan, E., Tengiz, I., Sekuri, C., Aliyev, E., Etemoglu, M., Sari, S. ve M. Akin, ‘‘Transbrachial coil occlusion of the large branch of an internal mammary artery coronary graft,’’ J. Card. Surg, 19, 45-6 (2004).(Case report)

• A28. Ercan, E., Bozdemir, H., Tengiz, I., Sekuri, C., Aliyev, E., Akilli, A. ve M. Akin, ‘‘Decreased Soluble Cell Adhesion Molecules After Tirofiban Infusion in Patients with Unstable Angina Pectoris,’’ Thromb. J, 2, 4 (2004).

• A29. Ercan, E., Tengiz, I., Sekuri, C., Sahin, F., Aliyev, E., Akin, M. ve U. Acikel, ‘‘Cardiac Thrombi in a Patients with Protein-C and S Deficiencies:A Case Report,’’ Thromb. J, 2, 2 (2004).